mo:re introduces a laboratory platform to automate the planning, culture, and analysis of complex 3D cell culture models. The user-friendly platform enables verifiable, standardized results without requiring expertise in specific organ systems. The Hamburg-based life science start-up mo:re announced the launch of their first product at the SLAS 2025 in San Diego, the world’s leading […]
2024 was characterized by continuity for INTEGRA Biosciences. With sales of CHF 156 million, the company remained at the previous year’s level despite a difficult first quarter. Compared to the period before the COVID-19 pandemic, the company has doubled in size, underlining its sustainable growth. Agility and growth in a challenging market environment The market […]
Investment from Audax Strategic Capital aims to help extend growth runway and accelerate M&A. NEW YORK & PITTSBURGH — Audax Strategic Capital (“ASC” or “Audax”), a provider of customized, mid-hold equity solutions, announced today an investment in TCP Analytical, a portfolio company of Riverarch Equity Partners (“Riverarch”) and an established manufacturer and distributor of specialty […]
SAN DIEGO — Telesis Bio, a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, today announced that it has entered into a convertible preferred stock purchase agreement (the Purchase Agreement) to sell shares of a new series of convertible preferred stock in a private […]
Aptco Group has entered into a strategic partnership with Tilleghem, a private equity investment company based in Ghent, Belgium, whereby Tilleghem has acquired a minority stake in Aptco Group. This collaboration marks a significant step in Aptco Group’s growth trajectory, positioning the company for accelerated international expansion and long-term success. The daily operations and responsibilities […]
AI platform combined with autonomous labs will accelerate discovery across every domain of science Company has raised $200M in seed financing to further develop platform and build first AI Science Factories CAMBRIDGE, MA – Flagship Pioneering, the bioplatform innovation company, today unveiled Lila Sciences, a company building the world’s first scientific superintelligence platform and fully […]
QT Sense, a deep-tech startup that emerged from the research group of Prof. Dr Schirhagl of the UMCG, has successfully raised €6 million in funding to advance its cutting-edge quantum sensing technology. The funding round was led by QDNL Participations and an angel investor. Additionally, QT Sense, as part of a consortium, secured a grant […]
Investment lead by Foresight Group secured alongside Polish grant funding agency PARP Scottishbiotech engineering company uFraction8 has secured £3.4m in new investment following the completion of a funding round led by the Foresight Group. Based in Falkirk with a fully-owned subsidiary in Poland, uFraction8’s microfiltration technology is designed to optimise cell and biomass production,offering […]
Albert’s AI-enabled platform transforms materials science R&D and accelerates chemical innovation OAKLAND, Calif. — Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials science through the application of AI and machine learning, today announced a growth funding round led by J.P. Morgan Private Capital’s Growth Equity Partners, with participation from Coatue and TCV. This […]
Atrandi Biosciences Raises $25M Series A Led by Lux Capital to Drive the Future of Single-Cell Multiomics with Semi-Permeable Capsule Technology Funding Led by Lux Capital, with participation from Vsquared Ventures, Practica Capital, Metaplanet and GRIDS Capital, to Drive Expansion in the U.S. and Scale Proprietary SPC Technology VILNIUS, LITHUANIA – Atrandi Biosciences, a life […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
